The activation of the JAK-STAT pathway is triggered by the action of interleukin-4 and interleukin-5, which assume a critical role in the development of skin injuries associated with AD by facilitating the action of proinflammatory cytokines and angiogenic mediators (Hossain et al., 2021). This evidence concerns the gene SOAT1 and Alzheimer disease.